Advanced Search

    column
    Opportunities and Challenges, as well as Hope and Glory, Coexist: Initial Treatment Strategy for Non-Resectable Locally Advanced / Metastatic Non-Small Cell Lung Cancer
    XU Chun-wei, LV Tang-feng, SONG Yong
    2020, 20(1): 1-5. DOI: 10.12019/j.issn.1671-5144.2020.01.001
    Abstract FullText HTML PDF
    2019 Research Advances in Lung Cancer
    GAO Xin, ZHOU Qing, WU Yi-long
    2020, 20(1): 6-13. DOI: 10.12019/j.issn.1671-5144.2020.01.002
    Abstract FullText HTML PDF
    2019 Clinical Research Advances of Breast Cancer
    LAI Jian-guo, XIAO Wei-kai, LIAO Ning
    2020, 20(1): 14-16. DOI: 10.12019/j.issn.1671-5144.2020.01.003
    Abstract FullText HTML PDF
    Research Advances in CAR-T Cell Therapy for Hematologic Tumors in 2019
    GENG Su-xia, DU Xin
    2020, 20(1): 17-20. DOI: 10.12019/j.issn.1671-5144.2020.01.004
    Abstract FullText HTML PDF
    Research Advances of Malignant Lymphoma in 2019
    HUANG Ling, CHEN Lin-jie, JIANG Xin-miao, PANG Di-wen, CHEN Fei-li, WEI Xiao-juan, GUO Han-guo, LIU Si-chu, LIANG Zhan-li, LI Wen-yu
    2020, 20(1): 21-28. DOI: 10.12019/j.issn.1671-5144.2020.01.005
    Abstract FullText HTML PDF
    Review of Significant Advances in Clinical Trial of Hepatocellular Carcinoma in 2019
    MAI Qi-cong, HE Jian, CHEN Xiao-ming
    2020, 20(1): 29-31. DOI: 10.12019/j.issn.1671-5144.2020.01.006
    Abstract FullText HTML PDF
    2019 Clinical Research Advances in Gastrointestinal Cancer
    DONG Qiu-mei, MA Dong
    2020, 20(1): 32-34. DOI: 10.12019/j.issn.1671-5144.2020.01.007
    Abstract FullText HTML PDF
    Overall Survival of Osimertinib in Untreated Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation
    HE Yong, WANG Han-min
    2020, 20(1): 35-38. DOI: 10.12019/j.issn.1671-5144.2020.01.008
    Abstract FullText HTML PDF
    Difficult First-Line Treatment of Advanced Squamous Lung Cancer
    WANG Zhen, YAO Yi-hui
    2020, 20(1): 39-42. DOI: 10.12019/j.issn.1671-5144.2020.01.009
    Abstract FullText HTML PDF
    Efficacy of Nivolumab plus Ipilimumab as First-Line Treatment in Non-Small-Cell Lung Cancer
    DONG Xiao-rong, WANG Qian-yu
    2020, 20(1): 43-48. DOI: 10.12019/j.issn.1671-5144.2020.01.010
    Abstract FullText HTML PDF
    Overall Survival with Durvalumab after Chemoradio-therapy in Stage Ⅲ NSCLC
    JIANG Su-jing, XIE Cong-ying, LU Hong-lian
    2020, 20(1): 49-52. DOI: 10.12019/j.issn.1671-5144.2020.01.011
    Abstract FullText HTML PDF
    The Efficacy of Erlotinib Combined with Anti-Angiogenesis Treatment in Comparison with Erlotinib Alone as First-Line Treatment of EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    FENG Wei-neng, DENG Qiu-mei
    2020, 20(1): 53-57. DOI: 10.12019/j.issn.1671-5144.2020.01.012
    Abstract FullText HTML PDF
    Efficacy of Atezolizumab for First-Line Treatment of Metastatic Nonsquamous Non- Small Cell Lung Cancer
    CHI Yu-jia, ZHAO Jun, GAO Yu-er
    2020, 20(1): 58-60. DOI: 10.12019/j.issn.1671-5144.2020.01.013
    Abstract FullText HTML PDF
    Pressure Injury Prevention in Underweight Infants Underwent Cardiopulmonary Bypass Surgery Using Foam Dressings and Warm-Air Inflatable Blankets
    OUYANG Shu-yi, CHEN Ling, LU Chang-qing, HUANG Shi-jie, KE Ping-fang, ZHANG Xiao-ni, ZHOU Yan, CHENG Zhi-xing, CAO Dan
    2020, 20(1): 61-64. DOI: 10.12019/j.issn.1671-5144.2020.01.014
    Abstract FullText HTML PDF